• Learning Objective 1:Describe treatment modalities of metastatic hormone positive breast cancer.
  • Learning Objective 2:Discuss key clinical trials in this group of patients.
  • Learning Objective 3:Discuss future directions of treatment.

 

AND

 

 

Learning Objective 1:Prognostic differences between HPV positive and HPV negative oropharyngeal cancers

  • Learning Objective 2:Pathogenesis and genetic differences of HPV positive oropharyngeal cancer
  • Learning Objective 3:Basis for de-escalation of treatment for HPV positive oropharyngeal cancer
Session date: 
Monday, August 8, 2016 - 12:00pm to 1:00pm
Speaker Name: 
Anu Neerukonda & Jonathan Trujillo
Location: 
UCMC E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.